Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Alvotech Lines Up FDA Inspection Ahead Of Adalimumab Action
Reinspection Of Reykjavik Plant Scheduled For 6 March, Ahead Of 13 April Goal Date
Jan 19 2023
•
By
Dave Wallace
An FDA inspection of the Reykjavik plant is scheduled for 6 March • Source: Shutterstock
More from Biosimilars
More from Products